Also, a recent meta-analysis of OSCC confirmed that promoter hypermethylation of RASSF1A is connected with oral cancer risk (Wen et al. 2018) although, Koutsimpelas et al. (2012) observed hypermethylation of RASSF1A in only 13% of tumor samples examined. Here, RASSF1 is linked to neoplasm.